"Synergy Healthcare is a site management organization that is dedicated to creating the next generation of medicine and medical devices. Our processes and technology provide the infrastructure for physicians to participate in ground breaking research within their existing medical practices, provides CROs and Sponsors with the efficient research sites, and connects patients with potentially life altering therapies at no cost to them. By creating the infrastructure for medical practices and hospitals to engage in clinical research and integrating our patient-centric approach to clinical development, our network of sites provides Sponsors and CROs with the clinical expertise, patient population, and dedicated support needed to complete clinic"

During the past decade, Synergy Healthcare conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 2 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synergy Healthcare" #1 sponsor was "Pfizer" with 4 trials, followed by "Hepion Pharmaceuticals, Inc." with 2 trials sponsored, "Appili Therapeutics Inc." with 1 trials sponsored, "Averitas Pharma, Inc." with 1 trials sponsored and "Axcella Health, Inc" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synergy Healthcare" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Novo Nordisk A/S" with 1 trials as a collaborator and "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Synergy Healthcare" are "COVID-19" (3 trials), "Covid19" (3 trials), "Chronic Kidney Diseases" (1 trials), "Coronavirus Disease 2019" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Synergy Healthcare" in a lesser frequency.

Most popular intervention types in "Synergy Healthcare" are "Drug" (16 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials), "AXA1125" (1 trials) and "Bamlanivimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Synergy Healthcare" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Synergy Healthcare". undefined are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Synergy Healthcare, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Synergy Healthcare, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".